Skip to main content

Recommendations Developed to Prepare Patients for Oral Immunotherapy

Medically reviewed by Carmen Pope, BPharm. Last updated on April 19, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, April 19, 2024 -- In a research article published online April 8 in the Journal of Allergy and Clinical Immunology, consensus recommendations are presented for preparing and counseling patients and caregivers prior to oral immunotherapy (OIT) initiation.

Douglas P. Mack, M.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues reached consensus for four themes and 103 statements specific to OIT preparatory procedures. The authors note that 76 statements reached consensus for inclusion specific to the themes of general considerations for counseling patients about OIT; patient- and family-specific factors that should be addressed before initiation of and during OIT; indications for OIT initiation; and potential contraindications and precautions for OIT. Consensus was reached on nine themes on the OIT consent form, which included benefits, risks, outcomes, alternatives, risk mitigation, difficulties/challenges, discontinuation, office policies, and long-term management. On the consent information form, 71 statements were included from these themes.

"These families must provide the therapy every single day. That's why these guidelines are so important," Mack said in a statement. "Safety can be optimized to make sure that they understand what they're taking on, while ensuring that they are aware of the kinds of side-effects that can be dangerous."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Penicillin Allergy Can Be Delabeled by Nonallergy Providers

TUESDAY, April 9, 2024 -- Direct oral penicillin challenges (DPCs) can be delivered to patients with penicillin allergy labels (PALs) by nonallergy health care professionals...

Bypassing Oral Immunotherapy Buildup Safe in Children With Food Allergy

THURSDAY, March 21, 2024 -- An initial phase of multifood sublingual immunotherapy (SLIT) that bypasses oral immunotherapy (OIT) buildup is safe and effective, according to a...

American Academy of Allergy, Asthma & Immunology, Feb. 23 to 26

The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 23 to 26 in Washington, D.C., drawing participants from around the world...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.